Trends in incident hemodialysis access and mortality
- PMID: 25738981
- DOI: 10.1001/jamasurg.2014.3484
Trends in incident hemodialysis access and mortality
Abstract
Importance: Based on evidence of survival benefit when initiating hemodialysis (HD) via arteriovenous fistula (AVF) or arteriovenous graft (AVG) vs hemodialysis catheter (HC), the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative published practice guidelines in 1997 recommending 50% or greater AVF rates in incident HD patients. A decade after, lapses exist and the impact on HD outcomes is uncertain.
Objective: To assess the achievement of the practice goals for incident vascular access and the effects on HD outcomes.
Design, setting, and participants: This retrospective cohort study was conducted using the US Renal Data System. All patients with end-stage renal disease in the United States without prior renal replacement therapy who had incident vascular access for HD created between January 1, 2006, and December 31, 2010 (N = 510 000) were included.
Main outcomes and measures: Incident vascular access use rates and mortality. Relative mortality was quantified using multivariable Cox proportional hazard models. Coarsened exact matching and propensity score-matching techniques were used to better account for confounding by indication.
Results: Of 510 000 patients included in this study, 82.6% initiated HD via HC, 14.0% via AVF, and 3.4% via AVG. Arteriovenous fistula use increased only minimally, from 12.2% in 2006 to 15.0% in 2010. Patients initiating HD with AVF had 35% lower mortality than those with HC (adjusted hazard ratio, 0.65; 95% CI, 0.64-0.66; P < .001). Those initiating HD with AVF had 23% lower mortality than those initiating with an HC while awaiting maturation of an AVF (adjusted hazard ratio, 0.77; 95% CI, 0.76-0.79; P < .001).
Conclusions and relevance: Current incident AVF practice falls exceedingly short years after recommendations were made in 1997. The impact of this shortcoming on mortality for patients with end-stage renal disease is enormous. Functioning permanent access at initiation of HD confers lower mortality even compared with patients temporized with an HC while awaiting maturation of permanent access. A change of current policies and structured multidisciplinary efforts are required to establish matured fistulae prior to HD to ameliorate this deficit in delivering care.
Comment in
-
A call to action for pre-end-stage renal disease care.JAMA Surg. 2015 May;150(5):449. doi: 10.1001/jamasurg.2014.3499. JAMA Surg. 2015. PMID: 25738658 No abstract available.
-
Dialysis: Reducing central venous catheter use in haemodialysis.Nat Rev Nephrol. 2015 Jun;11(6):323-5. doi: 10.1038/nrneph.2015.56. Epub 2015 Apr 21. Nat Rev Nephrol. 2015. PMID: 25898354 No abstract available.
-
Major Effect of the Syndrome of Rapid-Onset End-Stage Renal Disease on the Use of Arteriovenous Fistulas: High Rates of Initiation of Hemodialysis With Hemodialysis Catheter in the United States.JAMA Surg. 2016 Jan;151(1):96. doi: 10.1001/jamasurg.2015.2430. JAMA Surg. 2016. PMID: 26444181 No abstract available.
-
One-Third of Patients in a National Cohort Initiating Hemodialysis With a Catheter Despite 6 Months of Nephrology Care.JAMA Surg. 2016 Jul 1;151(7):687. doi: 10.1001/jamasurg.2015.5559. JAMA Surg. 2016. PMID: 26914962 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
